View by Specialty

Trending

Graphical depiction of data presented in article
October 09, 2024
4 min read
Save

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

Cardiology News

SPONSORED CONTENT
October 10, 2024
3 min read
Save
Q&A: ‘First of its kind’ stent for neonates, very young with pulmonary stenosis approved

Q&A: ‘First of its kind’ stent for neonates, very young with pulmonary stenosis approved

In August, the FDA approved a novel miniaturized cardiac stent for infants and small children with coarctation of the aorta or pulmonary artery stenosis and can be expanded as they grew.

SPONSORED CONTENT
October 09, 2024
2 min read
Save

Hypertension common, predicted by older age, diabetes in early rheumatoid arthritis

Hypertension common, predicted by older age, diabetes in early rheumatoid arthritis

Hypertension is common in patients with early rheumatoid arthritis, and most frequently develops in older patients and those with traditional cardiovascular risk factors, according to data published in Rheumatology Advances in Practice.

SPONSORED CONTENT
October 09, 2024
3 min read
Save

Infants born after fertility treatment face greater risk for heart defects

Infants born after fertility treatment face greater risk for heart defects

Infants conceived after assisted reproductive technology had a 36% greater risk for being born with a major heart defect, results from a large cohort study published in the European Heart Journal showed.

Trending

Graphical depiction of data presented in article
October 09, 2024
4 min read
Save

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

SPONSORED CONTENT
October 09, 2024
4 min read
Save

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

Prior SARS-CoV-2 infection, especially for those requiring hospitalization, was associated with increased risk for heart attack and stroke for up to 3 years, even among people with no history of heart disease, researchers reported.

SPONSORED CONTENT
October 08, 2024
3 min read
Save

Having three or more metabolic risk factors raises diabetes risk in people with HIV

Having three or more metabolic risk factors raises diabetes risk in people with HIV

In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those without any risk factors, according to new findings from the REPRIEVE trial.

SPONSORED CONTENT
October 07, 2024
2 min read
Save

Top in cardiology: Obesity drug for those with heart failure; new cardiac PET agent

Top in cardiology: Obesity drug for those with heart failure; new cardiac PET agent

A novel controlled metabolic accelerator was associated with weight loss in patients with obesity-related heart failure with preserved ejection fraction, according to phase 2a study results.

SPONSORED CONTENT
October 07, 2024
3 min read
Save

Research effort may create ‘prototype’ to help cancer survivors manage cardiovascular risks

Research effort may create ‘prototype’ to help cancer survivors manage cardiovascular risks

An NCI grant will fund research designed to better coordinate care for cancer survivors with cardiovascular risks.

SPONSORED CONTENT
October 03, 2024
1 min read
Save

Study: No clear association between pet ownership and brain, heart health

Study: No clear association between pet ownership and brain, heart health

ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.

SPONSORED CONTENT
October 02, 2024
3 min read
Save

Systemic inflammation an ‘important risk factor’ for stroke, ILD in rheumatoid arthritis

Systemic inflammation an ‘important risk factor’ for stroke, ILD in rheumatoid arthritis

SAN DIEGO — Managing systemic inflammation is critical to reducing cardiovascular and pulmonary outcomes in patients with rheumatoid arthritis, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
October 01, 2024
3 min read
Save

Novel obesity agent linked to weight loss vs. placebo at 3 months in patients with HFpEF

Novel obesity agent linked to weight loss vs. placebo at 3 months in patients with HFpEF

In a phase 2a trial of patients with obesity-related HF with preserved ejection fraction, a novel controlled metabolic accelerator was associated with weight loss at 3 months compared with placebo.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails